Relevance of Minor Neuropsychological Deficits in Patients With Subjective Cognitive Decline.
Stark M, Wolfsgruber S, Kleineidam L, Frommann I, Altenstein S, Bartels C, Brosseron F, Buerger K, Burow L, Butryn M, Ewers M, Fliessbach K, Gabelin T, Glanz W, Goerss D, Gref D, Hansen N, Heneka MT, Hinderer P, Incesoy EI, Janowitz D, Kilimann I, Kimmich O, Laske C, Munk MH, Perneczky R, Peters O, Preis L, Priller J, Rauchmann BS, Rostamzadeh A, Roy-Kluth N, Sanzenbacher C, Schneider A, Schott BH, Spottke A, Spruth EJ, Teipel S, Vogt IR, Wiltfang J, Duzel E, Jessen F, Wagner M.
Stark M, et al.
Neurology. 2023 Nov 21;101(21):e2185-e2196. doi: 10.1212/WNL.0000000000207844. Epub 2023 Oct 11.
Neurology. 2023.
PMID: 37821235
Free PMC article.
We compared SCD patients with MNPD and those without MNPD with regard to CSF amyloid-beta (Abeta)42/Abeta40, phosphorylated tau (p-tau(181))(,) total tau and Abeta42/p-tau(181) levels, longitudinal cognitive composite trajectories, and risk of clinical …
We compared SCD patients with MNPD and those without MNPD with regard to CSF amyloid-beta (Abeta)42/Abeta40, phosphorylated tau (p- …